Get the Stockscreener App
24.00
1.03%
-0.25
After Hours:
24.00
Lifemd Inc stock is traded at $24.00, with a volume of 1,076.
It is down -1.03% in the last 24 hours and up +9.09% over the past month.
LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for care across various indications, including concierge care, men's sexual health, dermatology, and others in the United States. The company provides ShapiroMD, a telehealth platform brand that offers access to virtual medical treatment, prescription medications, patented-doctor formulated OTC products, and an FDA approved medical device for male and female hair loss, and female specific topical compounded medications for hair loss; RexMD, a men's telehealth brand that offers virtual medical treatment from licensed providers for a variety of men's health needs; LifeMD Primary Care, a personalized subscription-based virtual primary care platform that provides patients with primary care, urgent care, and chronic care needs, as well as .offers a mobile first platform that incorporates virtual consultations and treatment, prescription medications, diagnostics, and imaging; Cleared, a telehealth brand that provides personalized treatments for allergy, asthma, and immunology; and Nava MD, a female-oriented tele-dermatology and skincare brand that offers virtual medical treatment from dermatologists and other providers. It also offers PDFSimpli, an online software-as-a-service platform that allows users to create, edit, convert, sign, and share PDF documents. LifeMD sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was founded in 1994 and is headquartered in New York, New York.
See More
Previous Close:
$24.25
Open:
$24.05
24h Volume:
1,076
Relative Volume:
0.18
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+0.25%
1M Performance:
+9.09%
6M Performance:
+8.60%
1Y Performance:
+9.19%
1-Day Range:
$24.00
$24.05
1-Week Range:
$24.00
$24.78
52-Week Range:
$20.25
$27.44
Lifemd Inc Stock (LFMDP) Company Profile
Name
Lifemd Inc
Sector
Industry
Phone
866 351 5907
Address
236 Fifth Avenue, Suite 400, New York
Compare LFMDP with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LFMDP
Lifemd Inc
|
24.00 | 0 | 0 | 0 | 0 | 0.00 |
|
WBA
Walgreens Boots Alliance Inc
|
11.22 | 9.49B | 147.66B | -8.64B | -363.00M | -10.01 |
|
WGRX
Wellgistics Health Inc
|
2.71 | 231.67M | 0 | 0 | 0 | 0.00 |
|
HITI
High Tide Inc
|
2.40 | 194.25M | 376.07M | -22.41M | 18.73M | -0.298 |
|
PETS
Petmed Express Inc
|
3.62 | 74.78M | 270.52M | -6.08M | 17.42M | -0.2944 |
|
SCNX
Scienture Holdings Inc
|
0.92 | 11.90M | 0 | 0 | 0 | 0.00 |
Lifemd Inc Stock (LFMDP) Latest News
LifeMD Might Run Higher (NASDAQ:LFMD) - Seeking Alpha
LifeMD, Inc. Beat Analyst Profit Forecasts, And Analysts Have New Estimates - simplywall.st
LifeMD raises 2025 revenue guidance to $275M driven by telehealth growth - MSN
Trading (LFMD) With Integrated Risk Controls - news.stocktradersdaily.com
(LFMDP) Investment Report - news.stocktradersdaily.com
Cantor Fitzgerald maintains Overweight on LifeMD shares, target $15.00 By Investing.com - Investing.com Nigeria
LifeMD’s Earnings Call: Positive Growth and Strategic Expansion - TipRanks
Cantor Fitzgerald maintains Overweight on LifeMD shares, target $15.00 - Investing.com Australia
BTIG maintains Buy rating, $12 target on LifeMD shares By Investing.com - Investing.com Nigeria
LifeMD, Inc.'s (NASDAQ:LFMD) Shares Leap 50% Yet They're Still Not Telling The Full Story - simplywall.st
LifeMD, Inc. (NASDAQ:LFMD) Q1 2025 Earnings Call Transcript - Insider Monkey
BTIG maintains Buy rating, $12 target on LifeMD shares - Investing.com
LifeMD (LFMD) Exceeds Q1 Expectations and Raises 2025 Outlook - GuruFocus
LifeMD Inc (LFMD) Q1 2025 Earnings Call Highlights: Strong Telehealth Growth and Strategic ... - Yahoo Finance
LifeMD earnings beat by $0.07, revenue topped estimates - Investing.com Canada
LifeMD (LFMD) Reports Strong Q1 2025 Performance and Raises Guid - GuruFocus
LifeMD Inc Reports Q1 2025 Earnings: EPS of $0.01 Beats Estimates, Revenue Surges to $65.7 Million - GuruFocus
LifeMD Inc reports results for the quarter ended March 31Earnings Summary - TradingView
LifeMD, Inc. (LFMD) Q1 Earnings and Revenues Top Estimates - Yahoo Finance
Earnings call transcript: LifeMD Q1 2025 earnings beat expectations, stock rises - Investing.com
LifeMD (LFMD) Boosts FY25 Revenue and EBITDA Forecasts | LFMD Stock News - GuruFocus
LifeMD (LFMD) Surpasses Revenue Expectations with Strong Q1 Performance | LFMD Stock News - GuruFocus
LifeMD, Inc. SEC 10-Q Report - TradingView
LifeMD Reports First Quarter 2025 Results and Raises Full-Year 2025 Guidance - GlobeNewswire
LifeMD Crushes Q1 Expectations: 70% Telehealth Surge and Historic Profit Milestone - Stock Titan
LifeMD (LFMD) Sees High Call Activity Ahead of Earnings | LFMD Stock News - GuruFocus
LifeMD, Inc. Reports Strong Q1 2025 Results - TipRanks
LifeMD Inc (LFMD) Q1 2025 Earnings Report Preview: What To Expec - GuruFocus
LifeMD Inc (LFMD) Q1 2025 Earnings Report Preview: What To Expect - GuruFocus
Have LifeMD Insiders Been Selling Stock? - simplywall.st
Hims & Hers, LifeMD Stocks Surge On Novo Nordisk's Plan To Sell Wegovy Via Telehealth Operators - MSN
LifeMD Inc expected to post a loss of 5 cents a shareEarnings Preview - TradingView
LifeMD (LFMD) to Announce Q1 2025 Earnings and Host Conference C - GuruFocus
LifeMD (LFMD) Enhances Access to Wegovy with NovoCare Partnershi - GuruFocus
Novo Nordisk partners with Hims & Hers, Ro, LifeMD to offer discounted Wegovy - eMarketer
LifeMD expands access to weight management drug Wegovy - Investing.com
Why Hims & Hers Health and LifeMD Are Skyrocketing Today - Mitrade
Novo Nordisk partners with Ro, Hims and LifeMD to sell low-cost Wegovy - MSN
LifeMD Stock Pops As Company Expands Weight-Loss Offerings With Wegovy - Benzinga
Wegovy to be sold on Hims, Ro and LifeMD for reduced price - Yahoo
Hims & Hers, LifeMD Stocks Surge On Novo Nordisk’s Plan To Sell Wegovy Via Telehealth Operators By Stocktwits - Investing.com India
LifeMD and Hims & Hers Health shares surge on Novo Nordisk partnerships - Investing.com
LifeMD (LFMD) Expands Access to Wegovy with NovoCare Partnership - GuruFocus
LifeMD Expands Access to Weight-Loss Drug Wegovy; Shares Surge - marketscreener.com
LifeMD Shares Surge on Expanded Access to Wegovy - MarketWatch
LifeMD Announces Plans to Expand Affordable Access to Wegovy® fo - GuruFocus
LifeMD Announces Plans to Expand Affordable Access to Wegovy® for Cash-Pay Patients - The Manila Times
LifeMD Makes Wegovy More Affordable: New $499 Monthly Program Includes Home Delivery - Stock Titan
LifeMD buys key assets from Optimal Human Health MD - MSN
LifeMD, Inc. (NASDAQ:LFMD) Receives $11.00 Average Price Target from Brokerages - Defense World
LifeMD to Report First Quarter 2025 Financial Results on May 6 - GlobeNewswire
Lifemd Inc Stock (LFMDP) Financials Data
There is no financial data for Lifemd Inc (LFMDP). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
2.12%
0.97%
Cap:
|
Volume (24h):